Bide Pharmatech Co., Ltd. (SHA:688073)

Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	552.13	1,105	1,274	1,506	193.46	91.63
Trading Asset Securities	57.09	75.52	0.12	3.97	-	43
Cash & Short-Term Investments	609.22	1,181	1,274	1,510	193.46	134.63
Cash Growth	-52.48%	-7.33%	-15.61%	680.49%	43.70%	205.70%
Accounts Receivable	253.52	227.37	237.35	177.37	124.68	84.94
Other Receivables	13.98	15.39	10.66	16.79	9.89	8.25
Receivables	267.5	242.76	248.01	194.16	134.57	93.19
Inventory	801.9	760.22	699.43	521.86	476.55	218.84
Prepaid Expenses	-	4.19	5.61	2.47	0.04	0.73
Other Current Assets	28.62	20.7	33.92	16.19	13.1	10.23
Total Current Assets	1,707	2,209	2,261	2,245	817.71	457.62
Property, Plant & Equipment	158.16	166.88	97.32	75.45	60.04	15.33
Other Intangible Assets	3.83	3.95	0.6	0.21	0.44	0.68
Long-Term Deferred Tax Assets	15.32	14.74	18.36	3.88	2.97	3.94
Long-Term Deferred Charges	22.16	23.74	37.58	16.81	22.13	22.59
Other Long-Term Assets	-	-	-	18.25	2.84	7.53
Total Assets	2,669	2,418	2,415	2,359	906.13	507.68
Accounts Payable	230.87	216.32	179.57	167.37	206.07	83.18
Accrued Expenses	20.96	31.38	36.26	30.1	18.57	22.15
Short-Term Debt	252.48	30.18	0.23	9.61	0.07	17.06
Current Portion of Leases	12.21	14.06	15.88	-	-	-
Current Income Taxes Payable	36.39	12.85	6.49	6.22	8.39	8.37
Current Unearned Revenue	37	36.69	29.07	20.52	14.68	11.31
Other Current Liabilities	3.79	4.28	7.47	15.25	1.78	1.35
Total Current Liabilities	593.69	345.76	274.97	249.07	249.56	143.42
Long-Term Leases	35.58	37.95	41.19	31.21	27.71	-
Long-Term Deferred Tax Liabilities	6.63	7.2	8.06	2.77	-	-
Other Long-Term Liabilities	-	-	1.27	-	-	-
Total Liabilities	635.9	390.91	325.49	283.05	277.27	143.42
Common Stock	90.88	90.88	90.88	64.92	48.69	45
Additional Paid-In Capital	1,763	1,755	1,754	1,776	483.24	321.04
Retained Earnings	320.32	289.63	252.08	242.48	96.51	-1.07
Treasury Stock	-132.77	-99.99	-	-	-	-
Comprehensive Income & Other	-7.88	-8.6	-6.96	-7.25	0.43	-0.71
Shareholders' Equity	2,033	2,027	2,090	2,076	628.86	364.26
Total Liabilities & Equity	2,669	2,418	2,415	2,359	906.13	507.68
Total Debt	300.26	82.2	57.3	40.82	27.78	17.06
Net Cash (Debt)	308.96	1,099	1,217	1,469	165.68	117.57
Net Cash Growth	-74.11%	-9.72%	-17.17%	786.71%	40.92%	522.67%
Net Cash Per Share	3.47	12.35	13.44	19.93	2.47	1.90
Filing Date Shares Outstanding	87.68	88.33	90.88	90.88	68.16	68.16
Total Common Shares Outstanding	87.68	88.33	90.88	90.88	68.16	63
Working Capital	1,114	1,863	1,986	1,996	568.15	314.2
Book Value Per Share	23.19	22.95	22.99	22.84	9.23	5.78
Tangible Book Value	2,030	2,023	2,089	2,076	628.42	363.58
Tangible Book Value Per Share	23.15	22.91	22.98	22.84	9.22	5.77
Buildings	-	85.07	16.58	16.58	16.58	8.49
Machinery	-	45.93	47.23	35.62	21.9	11.74
Construction In Progress	-	15.41	-	5.1	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.